Over the 90-day window ending February 19, 2026, Lexaria Bioscience's three dominant insider ownership positions are held by Director Christopher Bunka (627.96K shares), President & Cso John Martin Docherty (54.08K shares), Chief Executive Officer Richard Christopher (50.00K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Christopher Bunka | 627,955 | 30 Jul, 2025 | |
| John Martin Docherty | President & Cso | 54,075 | 30 Jul, 2025 |
| Richard Christopher | Chief Executive Officer | 50,000 | 30 Jul, 2025 |
| William Edward Mckechnie | 13,191 | 30 Jul, 2025 | |
| Albert L Jr Reese | 5,917 | 25 May, 2022 | |
| Gregory Downey | Chief Financial Officer | 1,833 | 18 Oct, 2022 |
| Catherine C. Turkel | 1,500 | 13 Aug, 2024 | |
| Vanessa Carle | Secretary | 750 | 30 Jul, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 30 Jul, 2025 | Christopher Bunka | common shares | A | 11,900 | $0.91 | 254,412 | I | P |
| 29 Jul, 2025 | Christopher Bunka | common shares | A | 15,600 | $0.92 | 373,543 | D | P |
| 29 Jul, 2025 | Richard Christopher | common shares | A | 15,000 | $0.91 | 50,000 | D | P |
| 29 Jul, 2025 | John Martin Docherty | common shares | A | 5,376 | $0.93 | 54,075 | I | P |
| 29 Jul, 2025 | William Edward Mckechnie | common shares | A | 5,000 | $0.91 | 13,191 | D | P |
| 29 Jul, 2025 | Vanessa Carle | common shares | A | 750 | $0.91 | 750 | D | P |
| 07 Jan, 2025 | Christopher Bunka | common shares | A | 100,000 | $0.00 | 273,543 | D | A |
| 03 Dec, 2024 | Richard Christopher | - | - | 50,000 | D | |||
| 03 Dec, 2024 | Richard Christopher | common shares | A | 27,172 | $2.47 | 50,000 | D | P |
| 02 Dec, 2024 | Richard Christopher | common shares | A | 22,828 | $2.24 | 22,828 | D | P |
| 02 Dec, 2024 | Richard Christopher | - | - | 22,828 | D | |||
| 12 Aug, 2024 | Catherine C. Turkel | - | - | 1,500 | D | |||
| 12 Aug, 2024 | Catherine C. Turkel | common shares | A | 1,600 | $3.13 | 1,500 | D | P |
| 31 Jul, 2024 | Vanessa Carle | - | - | 2,567 | D | |||
| 31 Jul, 2024 | Vanessa Carle | common shares | D | 2,567 | $4.00 | 2,567 | D | S |
| 14 May, 2024 | Vanessa Carle | common shares | A | 2,500 | $1.15 | 67 | D | M |
| 09 Feb, 2023 | Catherine C. Turkel | Common Shares | A | 1,500 | $2.84 | 1,500 | D | P |
| 09 Feb, 2023 | Catherine C. Turkel | - | - | 1,500 | D | |||
| 14 Oct, 2022 | Gregory Downey | - | - | 1,833 | D | |||
| 14 Oct, 2022 | Gregory Downey | common shares | A | 121 | $2.09 | 1,833 | D | A |